Corcept Therapeutics (HTD) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

0 Followers

Earnings Data

Report Date

Nov 04, 2026

TBA (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

0.64

Last Year’s EPS

0.13

Same Quarter Last Year

Moderate Buy

Based on 4 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:HTD Upcoming Earnings

Corcept Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2026	2026 (Q3)	0.64 / -	0.13	―	―	―
Jul 29, 2026	2026 (Q2)	0.02 / 0.29	0.236	24.14% (+0.06)	―
Apr 30, 2026	2026 (Q1)	-0.09 / -0.24	0.138	-276.47% (-0.38)	―
Feb 24, 2026	2025 (Q4)	0.27 / 0.16	0.212	-23.08% (-0.05)	―
Nov 04, 2025	2025 (Q3)	0.13 / 0.13	0.334	-60.98% (-0.20)	―
Jul 31, 2025	2025 (Q2)	0.15 / 0.24	0.26	-9.38% (-0.02)	―
May 05, 2025	2025 (Q1)	0.12 / 0.14	0.203	-32.00% (-0.07)
Feb 26, 2025	2024 (Q4)	0.35 / 0.21	0.228	-7.14% (-0.02)	―
Oct 30, 2024	2024 (Q3)	0.23 / 0.33	0.228	46.43% (+0.11)	―
Jul 29, 2024	2024 (Q2)	0.19 / 0.26	0.203	28.00% (+0.06)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Corcept Therapeutics Inc. (CH:HTD) report earnings?

Corcept Therapeutics Inc. (CH:HTD) is schdueled to report earning on Nov 04, 2026, TBA (Confirmed).

What is Corcept Therapeutics Inc. (CH:HTD) earnings time?

Corcept Therapeutics Inc. (CH:HTD) earnings time is at Nov 04, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Corcept Therapeutics Inc. stock?

The P/E ratio of Corcept Therapeutics is N/A.

What is CH:HTD EPS forecast?

CH:HTD EPS forecast for the fiscal quarter 2026 (Q3) is 0.64.